5-butoxy-2-hydroxy-benzaldehyde | 41002-38-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: 5-butoxy-2-hydroxy-benzaldehyde
• 英文别名: 2-hydroxy-5-butoxybenzaldehyde；5-Butoxy-2-hydroxybenzaldehyde
• CAS: 41002-38-4
• 化学式: C₁₁H₁₄O₃
• 分子量: 194.23
• InChiKey: UGOPHUXHAJHSOP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-butoxy-2-hydroxy-benzaldehyde 在 镍 氢气 、 苄基三甲基氢氧化铵 、 potassium carbonate 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 、 苯 为溶剂， 反应 55.0h， 生成 4-(5-Butoxy-1-benzofuran-2-yl)pyrrolidin-2-one
  参考文献：
  名称：

  3-Benzo[b]furyl- and 3-benzo[b]thienylaminobutyric acids as GABAB ligands. Synthesis and structure-activity relationship studies

  摘要：

  Baclofen (beta-p-chlorophenyl GABA) is one of the selective agonists for the bicuculline-insensitive GABA(B) receptors. In the search for new compounds that bind to GABA(B) receptors it is very important to clarify the structural requirements. We report the syntheses of and binding studies on various S-heteroaromatic (benzo[b]furan and benzo[b]thiophen)aminobutyric acids. The 4-amino-3-(7-methyl-benzo[b]furan-2-yl)butanoic acid 8g is a potent and specific ligand for GABA(B) receptors, with an IC50 value of 5.4 mu M in the displacement of [H-3]GABA.

  DOI：

  10.1016/0223-5234(96)85165-8
• 作为产物：
  描述：

  4-正丁氧基苯酚 在 盐酸 、 sodium hydroxide 作用下， 以 正己烷 、 氯仿 、 乙酸乙酯 为溶剂， 生成 5-butoxy-2-hydroxy-benzaldehyde
  参考文献：
  名称：

  Therapeutic amines

  摘要：

  式I的化合物及其药学上可接受的盐，其中R.sup.1和R.sup.2分别为氢、烷基、环烷基、环烷基烷基、苯基烷基或烯基；或NR.sup.1 R.sup.2是杂环基团；A是可选择地由烷基取代的三亚甲基，苯环可选择地由卤素、烯基、氨基、氰基、脲基、烷基、碳酰胺基烷基、烷酰氨基、烷氧羰基、N-烷基-烷酰氨基、烷酰基及其胺基取代基取代；这些化合物是角鲨烯合成酶的抑制剂，因此在治疗降低胆固醇的疾病中有用。除了这些化合物在医学上的用途外，还提到了新颖的化合物、其制备方法和药物组合物。

  公开号：

  US05866611A1

文献信息

• Facile One-Pot Transformation of Phenols into<i>o</i>-Cyanophenols
  作者：Yuhta Nakai、Katsuhiko Moriyama、Hideo Togo

  DOI：10.1002/ejoc.201402817

  日期：2014.9

  The treatment of phenols with paraformaldehyde in the presence of MgCl2 and Et3N in THF at 80 °C, followed by reaction with molecular iodine and aq. ammonia at room temperature provided the corresponding o-cyanophenols in moderate to good yields. The present reaction is a one-pot transformation of phenols into o-cyanophenols using much less expensive reagents than are typically used; the reaction is

  在 MgCl2 和 Et3N 的四氢呋喃中，在 80 °C 下用多聚甲醛处理苯酚，然后与分子碘和水溶液反应。氨在室温下以中等至良好的产率提供相应的邻氰基酚。本反应是使用比通常使用的试剂便宜得多的试剂将苯酚一锅法转化为邻氰基苯酚；该反应不含过渡金属和氰化物。在我们从对溴苯酚制备非布司他的过程中强调了该反应的效用。
• A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors
  作者：Cecilia Mattsson、Peder Svensson、Clas Sonesson

  DOI：10.1016/j.ejmech.2013.11.035

  日期：2014.2

  A series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones (coumarins) have been synthesized and their inhibitory activity to human monoamine oxidase A (MAO A) and B (MAO B) determined. Incorporation of a basic amino function in the C3 position together with substitution at the C6 position produced novel coumarin compounds with selectivity for the MAO A subtype. Substitution in the C6 position

  已经合成了一系列的6-取代的3-（吡咯烷-1-基甲基）铬-2-酮（香豆素），并确定了它们对人单胺氧化酶A（MAO A）和B（MAO B）的抑制活性。在C3位上结合基本氨基官能团以及在C6位上取代产生了对MAOA A亚型具有选择性的新型香豆素化合物。在C6位置被较小的亲水基团取代，例如羟基（19，IC 50  = 1.46μM）或氨基（18，IC 50  = 3.77μM），是MAO A最有效和最具选择性的化合物。这些化合物还显示出优异的水溶性特性。给予化合物18 [6-氨基-3-（吡咯烷-1-基甲基）铬-2--2-]体内在大鼠脑中诱导的典型MAO A抑制神经递质代谢产物特征：3,4-二羟基苯基乙酸（DOPAC）和5-羟基吲哚乙酸（5-HIAA）降低，但3-甲氧基酪胺（3-MT）水平升高。
• MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR)
  申请人：Gossett Lynn Stacy

  公开号：US20080167310A1

  公开（公告）日：2008-07-10

  The present invention is directed to a compound of formula I, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomer thereof, which are useful in treating Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to Syndrome X as well as cardiovascular diseases.

  本发明涉及公式I的化合物及其药学上可接受的盐、溶剂化合物、水合物或立体异构体，其可用于治疗X综合症、II型糖尿病、高血糖、高血脂、肥胖症、凝血异常、高血压、动脉硬化以及与X综合症和心血管疾病有关的其他疾病。
• AMINES AS INHIBITORS OF SQUALENE SYNTHASE
  申请人：ZENECA LIMITED

  公开号：EP0589018A1

  公开（公告）日：1994-03-30
• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS
  申请人：Arvinas, Inc.

  公开号：US20170065719A1

  公开（公告）日：2017-03-09

  The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.